Establishes provisions relating to the collection and destruction of unused drugs. (BDR 54-564)
Summary
SB231 establishes a new set of state requirements for pharmacies and other Drug Enforcement Administration-registered collectors that maintain secure drug take-back bins for home-generated pharmaceutical waste. The bill requires collectors to comply with state and federal law, place bins in regularly monitored locations, post clear signage about acceptable items, limit public access to monitored hours, inspect bins and surrounding areas for tampering or diversion, keep inspection and related records for at least two years, and notify local law enforcement within one business day of suspected theft, tampering, or significant loss. It also prohibits collectors from charging customers to maintain the bin or perform the required compliance activities.
The bill also creates liability and regulatory protections for compliant collectors. A collector that follows the bill’s requirements is shielded from Board of Pharmacy discipline for injuries or harms directly resulting from maintaining a bin, except where gross negligence or willful and wanton misconduct is involved, and is exempt from local restrictions that would otherwise interfere with collection, transportation, treatment, or destruction of bin contents. The bill does not require any eligible entity to host a bin, and it does not require solid waste management systems to handle bin contents unless an existing agreement or plan already says so. It authorizes the Board of Pharmacy to adopt implementing regulations and defines key terms such as collector, home-generated pharmaceutical waste, and secure drug take-back bin.
Impact
SB231 amends Nevada pharmacy law in Chapter 639 of NRS by creating a new regulatory framework for secure drug take-back bins and the handling of unused medications. It affects DEA-registered collectors, the State Board of Pharmacy, local governments, and entities that host or operate medication disposal receptacles. The bill also directs the Department of Health and Human Services to allocate $500,000 from the Fund for a Resilient Nevada to the Board of Pharmacy to help pay for destruction of collected home-generated pharmaceutical waste, tying opioid-settlement-related funds to medication disposal infrastructure.
Sentiment
The bill appears to have broad bipartisan support and little visible opposition. It passed the Senate 21-0 and the Assembly 39-0, indicating unanimous support in both chambers. The overall sentiment reflected in the voting history is favorable, likely due to the bill’s public-health focus on safe disposal of unused drugs and reducing diversion or misuse.
Contention
No committee testimony or recorded debate was provided, and the final votes were unanimous, so there is no clear evidence of major contention. The main policy choices embedded in the bill are the compliance obligations placed on collectors, the liability protection for those who comply, the preemption of conflicting local restrictions, and the use of Fund for a Resilient Nevada money for bin destruction costs. Any potential concerns would likely center on operational burdens for collectors, local control over disposal programs, and the use of settlement funds, but those issues did not appear to generate recorded opposition in the available materials.